Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter in India – Healthy Inc

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg | Exporter
Product image for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Aluminium Hydroxide & Magnesium Trisilicate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | NFI |
| Product Type | Tablet |
| Category | Antiulcer drugs – Antacid |
| Subcategory | Antacid |
| Active Ingredient | Aluminium Hydroxide & Magnesium Trisilicate |
| Strength | 120 mg + 250 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antiulcer drugs – Antacid |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets. | ||||||||||||||||||||||||
| Side Effects | Common: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus. | ||||||||||||||||||||||||
| Warnings and Precautions | Masking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Aluminium Hydroxide & Magnesium Trisilicate or substituted benzimidazoles / antacids. 2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure). 3. Concurrent administration with rilpivirine-containing products. | ||||||||||||||||||||||||
| Drug Interactions | 1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH. 2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors. 3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg ManufacturerView product →
✚
Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg SupplierView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg ExporterView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg ManufacturerView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg SupplierView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →